431
Participants
Start Date
December 31, 2010
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Vildagliptin
vildagliptin 50mg bid
Placebo
Placebo 50mg bid
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Buizingen
Novartis Investigative Site, Blagoevgrad
Novartis Investigative Site, Genk
Novartis Investigative Site, Oostham
Novartis Investigative Site, Plovdiv
Novartis Investigative Site, Pleven
Novartis Investigative Site, Dimitrovgrad
Novartis Investigative Site, Mouscron
Novartis Investigative Site, Varna
Novartis Investigative Site, Wichelen
Novartis Investigative Site, Nazareth
Novartis Investigative Site, De Pinte
Novartis Investigative Site, Berlin
Novartis Investigative Site, Sanlúcar de Barrameda
Novartis Investigative Site, Potsdam
Novartis Investigative Site, Falkensee
Novartis Investigative Site, Lahti
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Alzira
Novartis Investigative Site, Münster
Novartis Investigative Site, Wetter
Novartis Investigative Site, Beckum
Novartis Investigative Site, Völlkingen
Novartis Investigative Site, Mammendorf
Novartis Investigative Site, Pie¿¿any
Novartis Investigative Site, Sulzbach-Rosenberg
Novartis Investigative Site, Bamberg
Novartis Investigative Site, Lichtenfels
Novartis Investigative Site, Helsinki
Novartis Investigative Site, Oulu
Novartis Investigative Site, Eisleben Lutherstadt
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Ľubochňa
Novartis Investigative Site, Levice
Novartis Investigative Site, Nové Zámky
Novartis Investigative Site, Košice
Novartis Investigative Site, Ružomberok
Novartis Investigative Site, Alicante
Novartis Investigative Site, Centelles
Novartis Investigative Site, Truro
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Exeter
Novartis Investigative Site, Stevenage
Novartis Investigative Site, Wiltshire
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY